El primer episodio estará dedicado a uno de los grandes campos de la innovación a nivel mundial, uno de los que más dudas y controversias genera y que, en tiempos de pandemia y de vacunas, está de plena actualidad. Hablaremos de las patentes biotecnológicas con la participación de Nicolás Vincent Ruiz, Global Intellectual Property Head de ESTEVE, junto a Patricia Ramos, directora Área Patentes PONS IP y Ana Herrera Arroyo, responsable de Biotecnología del Área Patentes PONS IP a la que también hemos entrevistado. Para la firma invitada, contaremos con la participación de José Antonio Gil Celedonio, director de la Oficina Española de Patentes y Marcas (OEPM).
IP newsthat
may interest you
The emergence of artificial intelligence (AI) in the creative scope is transforming the way cultural and artistic content is envisaged, produced and distributed. From music and literature to film and visual arts, AI-based tools have opened up new possibilities, but...
By Luis Ignacio Vicente, Strategic Counsel at PONS IP A few days ago, the European Commission published its strategy to make the European Union the best place in the world to create, scale up and consolidate technology companies. This document...
PONS IP has once again been recognised as one of the world’s leading intellectual property consulting firms by IAM Patent 1000 – The World’s Leading Patent Professionals, consolidating its position as a leading firm in patent processing services in Spain,...
NEWSLETTER
All the IP News
in your e-mail
Find out all the latest information on IP to boost the development of your organisation.
Subscribe to our bimonthly newsletter

International Awards
and Recognitions
